tradingkey.logo
tradingkey.logo
Search

Profound Medical Corp

PROF
Add to Watchlist
6.100USD
+0.240+4.10%
Close 09-21 16:00ET
221.94MMarket Cap
LossP/E TTM

Profound Medical Corp (PROF) Revenue Performance

Updated: Jun 30, 2026

Last year, Profound Medical Corp generated 9.74M USD for its biggest-performing segment, Contracts with Customers. The USA made the largest contribution, accounting for 12.24M USD last year. For the latest quarter, Profound Medical Corp reported the revenue of 1.98M USD for the period ending 2025-06-30, which came from the top-performing segment, Contracts with Customers. USA contributed the highest revenue, at 1.75M USD.

By Business

Annual
Annual
Quarterly
Contracts with Customers
Leasing
FY2024
FY2023
Contracts with Customers
9.74M(91.20%)
5.90M(81.94%)
Leasing
940.00K(8.80%)
1.30M(18.06%)

By Region

Annual
Annual
Quarterly
USA
Canada
Germany
Finland
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
USA
12.24M(76.07%)
7.35M(68.82%)
5.13M(71.20%)
3.40M(50.82%)
2.09M(30.41%)
--(--)
--(--)
Canada
3.08M(19.13%)
2.44M(22.84%)
230.00K(3.19%)
1.49M(22.30%)
2.08M(30.22%)
5.22M(71.50%)
2.42M(58.10%)
Germany
773.00K(4.80%)
891.00K(8.34%)
1.84M(25.60%)
1.80M(26.88%)
2.71M(39.37%)
2.08M(28.50%)
1.75M(41.90%)
Finland
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.